The Kidney Cancer Association held a "Survivors' Conference" on Saturday, April 16, 2016 at MD Anderson in Houston.
The KCA also kindly recorded a video (here).
I have reproduced particular slides of interest from Nizar Tannir's nccRCC presentation below:
So what "process" does a doctor follow to determine the appropriate treatment for kidney cancer? I asked Memorial Sloan Kettering's Dr. James Hsieh about this and he sent the attached graphic. For those without 20/40 vision, I describe the graphic here.
A discussion of the ins and outs of clinical trials is here. You can research clinical trials using the sites listed below:
Topics include FAQs, Kidney Cancer Types. Cancer Biology. and Clinical Trial Lists. A site summary indexed by "Kidney Cancer Type" is below.
Dr. Hsieh specializes in treating kidney cancers. His laboratory primarily focuses its efforts on translational kidney cancer research.
This site is meant for patients who receive a rare Kidney Cancer diagnosis and physicians who give them.
This site's information is vetted by practicing physician scientists who work in the field of rare kidney cancers.
Kidney Cancer is not just one disease. There are a number of different cell types, each of which responds somewhat differently to treatment. Dr. W.
RareKidneyCancer.org launched today. It was conceived at the Kidney Cancer Association meeting in November 2015 at Miami Bay Biscayne. There, with the kind permission of the KCA organizers, we were able to approach physicians at the conference and ask one question "What is the biggest bottleneck in creating new treatments for rare kidney cancers"?
